Just In
- 7 min ago When Will Vaishakh Month 2024 Start? Vrats And Festivals That Will Fall This Month, Complete List!
- 1 hr ago Vikata Sankashti Chaturthi 2024: Lord Ganesha Mantras To Chant On This Auspicious Day
- 8 hrs ago Backless Dress: 7 Tips For Choosing Perfect Bra For Backless Outfits And Turn Heads Wherever You Go
- 17 hrs ago Summer Style: 6 Must-Try Colors To Stay Fashionably Cool Like B-Town Divas!
Don't Miss
- Sports Pakistan Cricket Team: Two Pakistan players ruled out of New Zealand T20I Series
- Finance HCL Tech Q4 Results, Dividend: EBIT Margins May Drop; Deal Wins, FY25 Guidance To Be Watched
- Education JEE Main Result 2024 Out, Telangana's 15 Toppers Shine, Check Statewise List of 56 Candidates with Perfect 100
- News Mangalsutra Row: Did Indira Gandhi Donate Gold During The 1962 War? The Facts Behind Priyanka's Claim
- Movies Kota Factory 3 OTT Release Date, Platform: When Will Jitendra Kumar's Web Series Premiere On Netflix?
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
- Technology OPPO Find X7 Ultra Camera Deep-Dive: Pushing the Boundaries of Photography on a Smartphone
- Automobiles Aston Martin Vantage Launched In India At Rs 3.99 Crore
No Clear Evidence Yet On Omicron's Transmissibility, Immune Evasion, Severity In India: INSACOG
There is no clear evidence yet on the transmissibility, immune evasion or severity of Omicron in India, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its latest bulletin while noting that the variant continues to grow rapidly as a variant of concern globally.
The bulletin, dated December 13 and published on Monday, said public health measures and investigations are being conducted to look into the new variant.
"At this time, there is no clear evidence regarding transmissibility, immune evasion, or severity in India," INSACOG said. It further said that while the Delta variant, including its B.1.617.2 (AY) and AY.x sublineages, continues to be the main variant of concern globally, Omicron continues to grow rapidly.
"Cases have continued to increase in South Africa, with a smaller but clear rise in hospitalizations. Pending complete genomic sequencing, in the UK, S-gene target failure has shown a very rapid increase in likely Omicron cases and this would represent a significant growth advantage against Delta," the INSACOG said.
The consortium said that while there are some indicators that the disease may be milder with Omicron, there is insufficient data to determine whether this is because of prior infections or vaccination.
"There is insufficient data for Omicron severity in unvaccinated or partially vaccinated older subjects," INSACOG said.
- healthXBB.1.16: Symptoms; Are Vaccines Useful? WHO Concerned Over Recent COVID Spike In India
- disorders cureCommon COVID Symptoms In Fully Vaccinated Individuals: What You Should Know
- wellnessMild COVID Linked To Life-Threatening Blood Clots, Increased Risk Of Cardiovascular Disease; Study
- wellnessCOVID-19 Variants In India: New COVID Variant May Pose Threat To Elderly People
- basicsCovid-19 Linked To Early Onset Of Periods: What You Need To Know
- wellnessCOVID XBB Variants Of Omicron In India: What You Should Know
- disorders cureNew Omicron Subvariant BQ.1 Detected In Maharashtra: What You Should Know
- disorders cureOmicron BF.7 In India, Risk Of Fresh Wave During Diwali: What You Should Know
- wellnessOld Age Is A Risk Factor For Pneumonia Due To The Omicron Variant: Study
- disorders cureWhat Is ‘Centaurus,’ New Fast-Spreading Covid Variant: Everything You Need To Know
- health75 Years Of Independence, 75 Days Of Free COVID Booster Shots; For Everyone Aged 18-59 From 15 July
- wellnessWhat Are The Health Risks Of Getting COVID The Second Or Third Time? 7 Important Points